- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alembic Pharmaceuticals Limited — Updates, 07-11-2025: Press Release
07-11-2025 | 12:37 pm
07-11-2025 | 12:37 pm
Alembic Pharma gets USFDA final approval for Dasatinib Tablets. This generic drug targets a significant US$ 101.7 Cr market, a key business development for future growth.
No comments yet. Be the first to comment!